Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Front Immunol ; 14: 1286474, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-38035103

RESUMO

Low-density lipoprotein receptor-related protein-associated protein 1 (LRPAP1), also known as receptor associated protein (RAP), is an endoplasmic reticulum (ER) chaperone and inhibitor of LDL receptor related protein 1 (LRP1) and related receptors. These receptors have dozens of physiological ligands and cell functions, but it is not known whether cells release LRPAP1 physiologically at levels that regulate these receptors and cell functions. We used mouse BV-2 and human CHME3 microglial cell lines, and found that microglia released nanomolar levels of LRPAP1 when inflammatory activated by lipopolysaccharide or when ER stressed by tunicamycin. LRPAP1 was found on the surface of live activated and non-activated microglia, and anti-LRPAP1 antibodies induced internalization. Addition of 10 nM LRPAP1 inhibited microglial phagocytosis of isolated synapses and cells, and the uptake of Aß. LRPAP1 also inhibited Aß aggregation in vitro. Thus, activated and stressed microglia release LRPAP1 levels that can inhibit phagocytosis, Aß uptake and Aß aggregation. We conclude that LRPAP1 release may regulate microglial functions and Aß pathology, and more generally that extracellular LRPAP1 may be a physiological and pathological regulator of a wide range of cell functions.


Assuntos
Peptídeos beta-Amiloides , Proteína Associada a Proteínas Relacionadas a Receptor de LDL , Microglia , Animais , Humanos , Camundongos , Peptídeos beta-Amiloides/metabolismo , Proteínas de Transporte/metabolismo , Linhagem Celular , Células Cultivadas , Fagocitose , Proteína Associada a Proteínas Relacionadas a Receptor de LDL/metabolismo
2.
Front Immunol ; 13: 859686, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35514983

RESUMO

Calreticulin is a chaperone, normally found in the endoplasmic reticulum, but can be released by macrophages into the extracellular medium. It is also found in cerebrospinal fluid bound to amyloid beta (Aß). We investigated whether brain cells release calreticulin, and whether extracellular calreticulin had any effects on microglia and neurons relevant to neuroinflammation and neurodegeneration. We found that microglia release nanomolar levels of calreticulin when inflammatory-activated with lipopolysaccharide, when endoplasmic reticulum stress was induced by tunicamycin, or when cell death was induced by staurosporine, and that neurons release calreticulin when crushed. Addition of nanomolar levels of extracellular calreticulin was found to chemoattract microglia, and activate microglia to release cytokines TNF-α, IL-6 and IL-1ß, as well as chemokine (C-C motif) ligand 2. Calreticulin blocked Aß fibrillization and modified Aß oligomerization, as measured by thioflavin T fluorescence and transmission electron microscopy. Extracellular calreticulin also altered microglial morphology and proliferation, and prevented Aß-induced neuronal loss in primary neuron-glial cultures. Thus, calreticulin is released by microglia and neurons, and acts: as an alarmin to recruit and activate microglia, as an extracellular chaperone to prevent Aß aggregation, and as a neuroprotectant against Aß neurotoxicity.


Assuntos
Peptídeos beta-Amiloides , Síndromes Neurotóxicas , Peptídeos beta-Amiloides/metabolismo , Encéfalo/metabolismo , Calreticulina/metabolismo , Células Cultivadas , Humanos , Microglia/metabolismo , Síndromes Neurotóxicas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...